London Daily

Focus on the big picture.
Saturday, Aug 02, 2025

Explainer: What Do The UK Allergic Reaction Cases Mean For Pfizer Vaccine

Explainer: What Do The UK Allergic Reaction Cases Mean For Pfizer Vaccine

UK officials said there have been two reports of anaphylaxis and one report of a possible allergic reaction since rollout began.

Britain's medicines regulator has advised people with a history of significant allergies not to get the Pfizer-BioNTech COVID-19 vaccine after two people reported adverse reactions on the first day of its rollout in the UK. Here are some questions and answers about the cases and what they might mean.

What Exactly Happened?


UK officials said there have been two reports of anaphylaxis and one report of a possible allergic reaction since rollout began.

Anaphylaxis can cause throat swelling, breathing trouble and difficulty swallowing, according to the American Academy of Allergy, Asthma & Immunology.

Anaphylaxis is an overreaction of the body's immune system, which the UK National Health Service describes as severe and sometimes life-threatening.

Who Should Not Get The Vaccine According To UK Regulators?


British regulators initially responded by saying anyone with a history of a significant allergic reaction to a vaccine, medicine or food should not take the shot.

An adviser to the group later said it was "tweaking" advice in part to say a food allergy was not a risk. Late on Wednesday, the UK regulator said anyone with a history of anaphylaxis to a vaccine, medicine or food should not get the vaccine. Pfizer had excluded people with a history of significant adverse reaction to vaccines or its vaccine's ingredients from late-stage trials.

How does this affect prospects for US authorization?


US regulators are expected to consider emergency authorization of the Pfizer vaccine soon after a Thursday meeting of advisers. Moncef Slaoui, who is spearheading the U.S government's vaccine development efforts, said on Wednesday he expected the British allergic reactions would be considered in the US authorization process and that people with known severe allergic reactions probably should not take the vaccine until more was understood.

What do doctors say?


Some praised UK regulators' caution, while others said broad restrictions were not warranted by available evidence. "For the general population, this does not mean that they would need to be anxious about receiving the vaccination," said Stephen Evans, a professor of pharmacoepidemiology at the London School of Hygiene & Tropical Medicine. What would be wise, he said, would be "for anyone who has known severe allergic reaction such that they need to carry an EpiPen to delay having a vaccination until the reason for the allergic reaction has been clarified.

"Mayo Clinic virologist Gregory Poland, who has advised U.S regulators, described Britain's early reaction as "overdoing it," pointing to the initial response about food allergies, which he said "have nothing to do with this."

"I would have said, 'If you've had anaphylactic-level reactions to vaccines, we want to know about that so we take extra care,'" he said

"That doesn't mean I wouldn't immunize you. But I would do it in a more controlled setting."

Peter Openshaw, a professor of experimental medicine at Imperial College London, praised the way the reactions had been handled.

"The fact that we know so soon about these two allergic reactions and that the regulator has acted on this to issue precautionary advice shows that the monitoring system is working well," he said.

Mitchell Grayson, director of the division of allergy and immunology at Nationwide Children's Hospital in Ohio, voiced concern over how the issue might reduce interest in vaccinations.

"I'm worried the whole event will cause millions of people to choose not to get vaccinated because of what they heard," he said.

How common are severe or significant allergies?


In the UK in 2012 there were around seven hospital admissions per 100,000 people for severe allergies.

This included different triggers such as foods, drugs and insect stings," said Louisa James, a expert in immunology at Queen Mary University of London

Fatalities remain very rare and have not increased even as hospital admissions have risen in many countries.

Newsletter

Related Articles

0:00
0:00
Close
Trump Administration Finalizes Broad Tariff Increases on Global Trade Partners
J.K. Rowling Limits Public Engagements Citing Safety Fears
JD.com Launches €2.2 Billion Bid for German Electronics Retailer Ceconomy
Azerbaijan Proceeds with Plan to Legalise Casinos on Artificial Islands
Former Judge Charged After Drunk Driving Crash Kills Comedian in Brazil
Jeff Bezos hasn’t paid a dollar in taxes for decades. He makes billions and pays $0 in taxes, LEGALLY
China Increases Use of Exit Bans Amid Rising U.S. Tensions
IMF Upgrades Global Growth Forecast as Weaker Dollar Supports Outlook
Procter & Gamble to Raise U.S. Prices to Offset One‑Billion‑Dollar Tariff Cost
House Republicans Move to Defund OECD Over Global Tax Dispute
Botswana Seeks Controlling Stake in De Beers as Anglo American Prepares Exit
Trump Administration Proposes Repeal of Obama‑Era Endangerment Finding, Dismantling Regulatory Basis for CO₂ Emissions Limits
France Opens Criminal Investigation into X Over Algorithm Manipulation Allegations
A family has been arrested in the UK for displaying the British flag
Mel Gibson refuses to work with Robert De Niro, saying, "Keep that woke clown away from me."
Trump Steamrolls EU in Landmark Trade Win: US–EU Trade Deal Imposes 15% Tariff on European Imports
ChatGPT CEO Sam Altman says people share personal info with ChatGPT but don’t know chats can be used as court evidence in legal cases.
The British propaganda channel BBC News lies again.
Deputy attorney general's second day of meeting with Ghislaine Maxwell has concluded
Controversial March in Switzerland Features Men Dressed in Nazi Uniforms
Politics is a good business: Barack Obama’s Reported Net Worth Growth, 1990–2025
Thai Civilian Death Toll Rises to 12 in Cambodian Cross-Border Attacks
TSUNAMI: Trump Just Crossed the Rubicon—And There’s No Turning Back
Over 120 Criminal Cases Dismissed in Boston Amid Public Defender Shortage
UN's Top Court Declares Environmental Protection a Legal Obligation Under International Law
"Crazy Thing": OpenAI's Sam Altman Warns Of AI Voice Fraud Crisis In Banking
The Podcaster Who Accidentally Revealed He Earns Over $10 Million a Year
Trump Announces $550 Billion Japanese Investment and New Trade Agreements with Indonesia and the Philippines
US Treasury Secretary Calls for Institutional Review of Federal Reserve Amid AI‑Driven Growth Expectations
UK Government Considers Dropping Demand for Apple Encryption Backdoor
Severe Flooding in South Korea Claims Lives Amid Ongoing Rescue Operations
Japanese Man Discovers Family Connection Through DNA Testing After Decades of Separation
Russia Signals Openness to Ukraine Peace Talks Amid Escalating Drone Warfare
Switzerland Implements Ban on Mammography Screening
Japanese Prime Minister Vows to Stay After Coalition Loses Upper House Majority
Pogacar Extends Dominance with Stage Fifteen Triumph at Tour de France
CEO Resigns Amid Controversy Over Relationship with HR Executive
Man Dies After Being Pulled Into MRI Machine Due to Metal Chain in New York Clinic
NVIDIA Achieves $4 Trillion Valuation Amid AI Demand
US Revokes Visas of Brazilian Corrupted Judges Amid Fake Bolsonaro Investigation
U.S. Congress Approves Rescissions Act Cutting Federal Funding for NPR and PBS
North Korea Restricts Foreign Tourist Access to New Seaside Resort
Brazil's Supreme Court Imposes Radical Restrictions on Former President Bolsonaro
Centrist Criticism of von der Leyen Resurfaces as she Survives EU Confidence Vote
Judge Criticizes DOJ Over Secrecy in Dropping Charges Against Gang Leader
Apple Closes $16.5 Billion Tax Dispute With Ireland
Von der Leyen Faces Setback Over €2 Trillion EU Budget Proposal
UK and Germany Collaborate on Global Military Equipment Sales
Trump Plans Over 10% Tariffs on African and Caribbean Nations
Flying Taxi CEO Reclaims Billionaire Status After Stock Surge
×